the safety and efficacy of intralesionally administered interferon alfa-2b were assessed in 11 patients suffering from condylomata acuminata for four to 10 months for whom application of podophyllum resin had proved unsuccessful .
C0021735
interferon alfa-2b
C0009663
condylomata acuminata